Univest
Univest
  • Markets

Omaxe vs Nifty 50: Share Price Performance Compared

  • October 9, 2026
  • Posted by: Kunal Singla
  • Category: Market
No Comments
Omaxe vs Nifty 50: Share Price Performance Compared

Omaxe share price Rs 98.42 on NSE. Omaxe vs Nifty 50 over 1 year: +22.96% vs -11.71%. 52-week high Rs 138.89, low Rs 62.50.

Quick Answer

Omaxe vs Nifty 50 gives a mixed picture: Omaxe has beaten the index in 4 of 5 time frames, and its 1-year return of +22.96% compares with -11.71% for the Nifty 50. Over three years, Omaxe gained 43.05% while the Nifty 50 gained 13.94%, a gap of 29.11 percentage points in its favour. At Rs 98.42, Omaxe is 29.1% below its 52-week high of Rs 138.89 and 57.5% above its 52-week low of Rs 62.50. Returns use NSE closing prices to 8 October 2026, and past performance does not indicate future results.

Omaxe vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Omaxe trades on the NSE under the symbol OMAXE, and its 1-month return of -18.90% compares with -5.12% for the Nifty 50 over the same period.

The Omaxe vs Nifty 50 comparison matters because Omaxe is a single stock exposed to its own business and sector developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Omaxe share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year and 3 years, using NSE closing data up to 8 October 2026.

Also read – Oil India vs Nifty 50: Share Price Performance Compared

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Omaxe vs Nifty 50: Performance at a Glance
  • Latest Close and 52-Week Range: Omaxe and the Nifty 50
  • Why the Omaxe vs Nifty 50 Gap Exists
  • Omaxe vs Nifty 50: Has Omaxe Beaten the Benchmark?
  • Risks of the Omaxe vs Nifty 50 Comparison
  • Conclusion
    • Has Omaxe outperformed the Nifty 50 in the last year?
    • How does Omaxe vs Nifty 50 look over 3 years?
    • What is the Omaxe share price today compared to Nifty 50?
    • What is the 52-week high and low of Omaxe?
    • Why does Omaxe show bigger price swings than the Nifty 50?
    • Is Omaxe a good long-term investment compared to a Nifty 50 index fund?

Omaxe vs Nifty 50: Performance at a Glance

The table below sets out the Omaxe vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 8 October 2026.

Time Frame Omaxe Return Nifty 50 Return Difference
1 Month -18.90% -5.12% -13.78 pp
3 Months +13.26% -7.22% +20.48 pp
6 Months +29.45% -6.49% +35.94 pp
1 Year +22.96% -11.71% +34.67 pp
3 Years +43.05% +13.94% +29.11 pp

On the Omaxe vs Nifty 50 scorecard, Omaxe has beaten the index over the latest 1-year window, returning +22.96% against -11.71% for the Nifty 50, a difference of 34.67 percentage points. The widest gap on the table is over six months, where Omaxe gained 29.45% while the Nifty 50 fell 6.49%, a difference of 35.94 percentage points in favour of the stock. The direction differs over the past year: Omaxe moved up while the Nifty 50 moved down.

Check the Univest Screener for live Omaxe and Nifty 50 data

Latest Close and 52-Week Range: Omaxe and the Nifty 50

Instrument Latest Close 52-Week High 52-Week Low Vs 52-Week High
Omaxe Rs 98.42 Rs 138.89 Rs 62.50 -29.1%
Nifty 50 22,231.80 26,373.20 22,179.90 -15.7%

Omaxe closed at Rs 98.42 on 8 October 2026, which is 29.1% below its 52-week high of Rs 138.89 and 57.5% above its 52-week low of Rs 62.50. The Nifty 50 closed at 22,231.80, 15.7% below its own 52-week high of 26,373.20, so the benchmark has also been through a drawdown over the past year.

Why the Omaxe vs Nifty 50 Gap Exists

Omaxe can move very differently from the Nifty 50 because it carries concentrated exposure to its own business and sector cycle, while the index blends 50 companies across banking, IT, energy and consumer sectors. The 52-week range shows it clearly: Omaxe has traded between Rs 62.50 and Rs 138.89, a spread of 122.2% from low to high, against 18.9% for the Nifty 50.

Company-specific triggers such as quarterly results, management commentary and order or capacity announcements can move Omaxe’s price sharply in either direction, while the Nifty 50’s return reflects the blended earnings of its constituents and is far less exposed to any single company’s news.

Download the Univest iOS App or Univest Android App to track Omaxe and Nifty 50 live on the go.

Omaxe vs Nifty 50: Has Omaxe Beaten the Benchmark?

Yes, over the past year. Omaxe returned +22.96% against -11.71% for the Nifty 50, a lead of 34.67 percentage points. Across the five time frames measured, Omaxe is ahead of the index over 3 months, 6 months, 1 year and 3 years and behind it over 1 month.

Risks of the Omaxe vs Nifty 50 Comparison

Reading too much into a Omaxe vs Nifty 50 comparison has real limitations. Point-to-point returns depend entirely on the start date chosen, so a stock that looks ahead of the index over one window can look behind over the next, and none of these figures predicts future returns.

Also read – Orchid Pharma vs Nifty 50: Returns Compared

Omaxe carries concentrated business and sector risk that a diversified index does not. Its 52-week range of Rs 62.50 to Rs 138.89 shows the scale of the swings a single-stock investor has lived with, against a range of 22,179.90 to 26,373.20 for the Nifty 50.

Conclusion

Omaxe vs Nifty 50 shows Omaxe ahead of the index in 4 of 5 time frames and behind in the rest, which is why the answer depends on the horizon an investor cares about. Volatility, liquidity and sector concentration deserve as much weight as the return history, and a SEBI-registered advisor can help fit Omaxe into a wider portfolio.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Has Omaxe outperformed the Nifty 50 in the last year?

Ans. Yes. Omaxe returned +22.96% over the past year while the Nifty 50 returned -11.71%, based on NSE closing prices to 8 October 2026.

How does Omaxe vs Nifty 50 look over 3 years?

Ans. Over three years Omaxe has returned +43.05% compared with the Nifty 50’s +13.94%, so in the Omaxe vs Nifty 50 comparison the stock has been ahead over this horizon.

What is the Omaxe share price today compared to Nifty 50?

Ans. Omaxe share price closed at Rs 98.42 on NSE on 8 October 2026, while the Nifty 50 closed at 22,231.80 in the same session.

What is the 52-week high and low of Omaxe?

Ans. Omaxe’s 52-week high is Rs 138.89 and its 52-week low is Rs 62.50, based on NSE data. The latest close of Rs 98.42 is 29.1% below the high.

Why does Omaxe show bigger price swings than the Nifty 50?

Ans. Omaxe carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies. Over 52 weeks Omaxe has traded in a 122.2% low-to-high range against 18.9% for the index, a key reason the Omaxe vs Nifty 50 return gap varies across time frames.

Is Omaxe a good long-term investment compared to a Nifty 50 index fund?

Ans. Omaxe’s suitability depends on an investor’s risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund. Long-term investors should weigh the Omaxe vs Nifty 50 return history alongside the company’s fundamentals and consult a SEBI-registered advisor.



Nifty 50 Stock Market
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply